Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | carbonic anhydrase XII | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | carbonic anhydrase XII | 354 aa | 295 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0056 | 0.0776 | 0.3579 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0056 | 0.0776 | 0.26 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0056 | 0.0776 | 0.26 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase R153.1, putative | 0.0081 | 0.1626 | 0.1626 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0193 | 0.5515 | 0.8032 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0054 | 0.0703 | 0.2223 |
Brugia malayi | Matrixin family protein | 0.0034 | 0.0028 | 0.0028 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0217 | 0.6335 | 1 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0081 | 0.1626 | 0.5142 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.12 | 0.1201 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0054 | 0.0703 | 0.2223 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.1572 | 0.1574 |
Chlamydia trachomatis | 1,4-alpha-glucan branching enzyme | 0.0096 | 0.2168 | 0.5 |
Mycobacterium tuberculosis | 1,4-alpha-glucan branching enzyme GlgB (glycogen branching enzyme) | 0.0096 | 0.2168 | 1 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0034 | 0.0028 | 0.0128 |
Echinococcus multilocularis | glucan (1,4 alpha), branching enzyme 1 | 0.0096 | 0.2168 | 0.6855 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0056 | 0.0776 | 0.26 |
Loa Loa (eye worm) | hypothetical protein | 0.0322 | 0.9991 | 1 |
Loa Loa (eye worm) | cyclic AMP specific phosphodiesterase PDE4D5A | 0.0081 | 0.1626 | 0.1627 |
Mycobacterium ulcerans | glycogen branching protein | 0.0096 | 0.2168 | 1 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0052 | 0.0645 | 0.0646 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.1493 | 0.1494 |
Plasmodium vivax | subtilisin-like protease 1 | 0.0215 | 0.6277 | 0.5 |
Brugia malayi | Phorbol esters/diacylglycerol binding domain | 0.0077 | 0.1502 | 0.1502 |
Toxoplasma gondii | glycosyltransferase | 0.0096 | 0.2168 | 0.3453 |
Schistosoma mansoni | lipoxygenase | 0.0054 | 0.0703 | 0.3243 |
Brugia malayi | Matrixin family protein | 0.0034 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | CAMK/PKD protein kinase | 0.0068 | 0.1209 | 0.121 |
Onchocerca volvulus | 0.0079 | 0.1572 | 1 | |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0042 | 0.0287 | 0.5 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0092 | 0.2012 | 0.6363 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.0034 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.2012 | 0.2014 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0056 | 0.0776 | 1 |
Brugia malayi | Matrixin family protein | 0.0034 | 0.0028 | 0.0028 |
Plasmodium falciparum | subtilisin-like protease 1 | 0.0215 | 0.6277 | 1 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0125 | 0.3162 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0096 | 0.2168 | 0.217 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0028 | 0.0028 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0092 | 0.2012 | 0.6363 |
Onchocerca volvulus | 0.0049 | 0.0525 | 0.3217 | |
Schistosoma mansoni | starch branching enzyme II | 0.0096 | 0.2168 | 1 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0092 | 0.2012 | 0.9283 |
Onchocerca volvulus | Matrilysin homolog | 0.0076 | 0.1476 | 0.9376 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0125 | 0.3162 | 1 |
Trichomonas vaginalis | amylase, putative | 0.0217 | 0.6335 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0287 | 0.0287 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0217 | 0.6335 | 1 |
Onchocerca volvulus | 0.0068 | 0.12 | 0.7588 | |
Trichomonas vaginalis | alpha-amylase, putative | 0.0217 | 0.6335 | 1 |
Entamoeba histolytica | alpha-amylase family protein | 0.0217 | 0.6335 | 1 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0056 | 0.0776 | 0.2454 |
Entamoeba histolytica | alpha-amylase family protein | 0.0217 | 0.6335 | 1 |
Brugia malayi | 1,4-alpha-glucan branching enzyme | 0.0096 | 0.2168 | 0.2168 |
Brugia malayi | Matrixin family protein | 0.0083 | 0.1714 | 0.1714 |
Loa Loa (eye worm) | CAMK/PKD protein kinase | 0.0077 | 0.1502 | 0.1503 |
Brugia malayi | Matrixin family protein | 0.0034 | 0.0028 | 0.0028 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.0525 | 0.242 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0056 | 0.0776 | 0.0776 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0092 | 0.2012 | 0.6363 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0034 | 0 | 0.5 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0056 | 0.0776 | 0.2454 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0082 | 0.1663 | 0.7671 |
Onchocerca volvulus | 0.0077 | 0.1493 | 0.9485 | |
Loa Loa (eye worm) | matrixin family protein | 0.0083 | 0.1714 | 0.1715 |
Trichomonas vaginalis | alpha-amylase, putative | 0.0217 | 0.6335 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0034 | 0 | 0.5 |
Toxoplasma gondii | alpha amylase, catalytic domain-containing protein | 0.0096 | 0.2168 | 0.3453 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0092 | 0.2012 | 0.6363 |
Toxoplasma gondii | subtilisin SUB1 | 0.0215 | 0.6277 | 1 |
Schistosoma mansoni | protein kinase C mu | 0.0077 | 0.1502 | 0.6928 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0028 | 0.0028 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0042 | 0.0287 | 0.0287 |
Toxoplasma gondii | 1,4-alpha-glucan-branching enzyme | 0.0096 | 0.2168 | 0.3453 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0081 | 0.1626 | 0.5142 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.12 | 0.1201 |
Brugia malayi | Hemopexin family protein | 0.0049 | 0.0525 | 0.0525 |
Brugia malayi | C1-like domain containing protein | 0.0077 | 0.1502 | 0.1502 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0092 | 0.2012 | 0.3206 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0034 | 0 | 0.5 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0076 | 0.1476 | 0.9376 |
Loa Loa (eye worm) | matrixin family protein | 0.0076 | 0.1476 | 0.1477 |
Giardia lamblia | 1,4-alpha-glucan branching enzyme | 0.0096 | 0.2168 | 1 |
Echinococcus granulosus | glucan 14 alpha branching enzyme 1 | 0.0096 | 0.2168 | 0.6855 |
Trichomonas vaginalis | amylase, putative | 0.0217 | 0.6335 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 2010 nM | Inhibition of human carbonic anhydrase 12 by stopped-flow CO2 hydrase assay | ChEMBL. | 24560739 |
Ki (binding) | > 50000 nM | Inhibition of human carbonic anhydrase 9 by stopped-flow CO2 hydrase assay | ChEMBL. | 24560739 |
Ki (binding) | > 50000 nM | Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay | ChEMBL. | 24560739 |
Ki (binding) | > 50000 nM | Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay | ChEMBL. | 24560739 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.